Literature DB >> 11247302

Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2.

S M Morris1, J A Cooper.   

Abstract

Disabled-2 (Dab2) is a widely expressed relative of Disabled-1, a neuron-specific signal-transduction protein that binds to and receives signals from members of the low-density lipoprotein receptor (LDLR) family. Members of the LDLR family internalize through clathrin-coated pits and vesicles to endosomes, from where they return to the cell surface through the secretory pathway. In this study, we show that the Dab2 phosphotyrosine-binding domain binds peptides containing the sequence FXN-PXY. This core sequence is found in the intracellular domains of LDLR family members and is important for receptor internalization. Dab2 transiently colocalizes with the LDLR in clathrin-coated pits, but is absent from endosomes and lysosomes. Dab2 is alternatively spliced and its localization depends on a region of the protein that contains two DPF motifs that are present in the p96 Dab2 protein and absent in the p67 splice variant. This region is sufficient to confer Dab2 binding to the alpha-adaptin subunit of the clathrin adaptor protein, AP-2. Overexpression of p96 but not of p67 Dab2 disrupts the localization of AP-2. These findings suggest that in addition to previously reported signal-transduction functions, Dab2 could also act as an adaptor protein that may regulate protein trafficking.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247302     DOI: 10.1034/j.1600-0854.2001.020206.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  99 in total

1.  Role of an intramolecular contact on lipoprotein uptake by the LDL receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochim Biophys Acta       Date:  2011-04-09

2.  The adaptor protein ARH escorts megalin to and through endosomes.

Authors:  Masaaki Nagai; Timo Meerloo; Tetsuro Takeda; Marilyn Gist Farquhar
Journal:  Mol Biol Cell       Date:  2003-10-03       Impact factor: 4.138

Review 3.  Clathrin-dependent endocytosis.

Authors:  Seyed Ali Mousavi; Lene Malerød; Trond Berg; Rune Kjeken
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 4.  Cargo- and compartment-selective endocytic scaffold proteins.

Authors:  Iwona Szymkiewicz; Oleg Shupliakov; Ivan Dikic
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 5.  Synaptic vesicle endocytosis.

Authors:  Yasunori Saheki; Pietro De Camilli
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

6.  AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.

Authors:  Jacob Bendor; José E Lizardi-Ortiz; Robert I Westphalen; Markus Brandstetter; Hugh C Hemmings; David Sulzer; Marc Flajolet; Paul Greengard
Journal:  EMBO J       Date:  2010-07-27       Impact factor: 11.598

7.  The NECAP PHear domain increases clathrin accessory protein binding potential.

Authors:  Brigitte Ritter; Alexei Yu Denisov; Jacynthe Philie; Patrick D Allaire; Valerie Legendre-Guillemin; Peter Zylbergold; Kalle Gehring; Peter S McPherson
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

8.  Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor.

Authors:  Sanjay K Mishra; Peter A Keyel; Matthew J Hawryluk; Nicole R Agostinelli; Simon C Watkins; Linton M Traub
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

9.  AMN directs endocytosis of the intrinsic factor-vitamin B(12) receptor cubam by engaging ARH or Dab2.

Authors:  Gitte Albinus Pedersen; Souvik Chakraborty; Amie L Steinhauser; Linton M Traub; Mette Madsen
Journal:  Traffic       Date:  2010-01-18       Impact factor: 6.215

10.  Interference of human and Drosophila APP and APP-like proteins with PNS development in Drosophila.

Authors:  Gunter Merdes; Peter Soba; Alexander Loewer; Michaela V Bilic; Konrad Beyreuther; Renato Paro
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.